SuperworthCue Biopharma shares outstanding CUE
Diluted shares outstanding, averaged over each quarter, from 2017.
- Latest quarter, to Jun 30, 2026
- 6.3M
- On a year earlier
- +99.3%
- more shares
Cue Biopharma had 6.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 99.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 3.6M | +45% |
| FY2024 | 2.5M | +57% |
| FY2023 | 1.6M | +21% |
| FY2022 | 1.3M | +23% |
| FY2021 | 1.1M | +5% |
| FY2020 | 1M | +25% |
| FY2019 | 804.7K | +20% |
| FY2018 | 673.4K | +83% |
| FY2017 | 367.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 6.3M | +99% | |
| Q1 FY26 | 4.8M | +94% | |
| Q4 FY25 | 3.6M | +45% | |
| Q3 FY25 | 3.4M | +97% | |
| Q2 FY25 | 3.2M | +90% | |
| Q1 FY25 | 2.5M | +50% | |
| Q4 FY24 | 2.5M | +57% | |
| Q3 FY24 | 1.7M | +11% | |
| Q2 FY24 | 1.7M | +12% | |
| Q1 FY24 | 1.6M | +11% | |
| Q4 FY23 | 1.6M | +21% | |
| Q3 FY23 | 1.5M | +31% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Cue Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.